Gardeazabal, J. (Jesús)

Filtering

20231

Settings

Author search.filters.isAuthorOfPublication.7ca29a72-ddba-4654-b168-fc78ea6c2241

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
    (2023) López-Criado, P. (Pilar); Fernández-Morales, L.A. (Luis Antonio); Boada, A. (Aram); Feito-Rodríguez, M. (Marta); Carrera, C. (Cristina); Yelamos, O. (Oriol); Gonzalez-Cao, M. (María); Luna-Fra, P. (Pablo); Soria, A. (Ainara); Valles, L. (Lara); Antoñanzas-Basa, M. (Mónica); Martin-Algarra, S. (Salvador); Sequero, S. (Silvia); Martin-Liberal, J. (Juan); Villalobos, L. (Laura); Aguayo-Zamora, C. (Cristina); Cruz, R. (Raquel); Marquez-Rodas, I. (Iván); Maldonado-Seral, C. (Cayetana); Manzano, J.L. (José Luis); García-Castaño, A. (Almudena); Puig, S. (Susana); González-Barrallo, I. (Inés); López-Castro, R. (Rafael); Cerezuela, P. (Pablo); Muñoz, E. (Eva); Gardeazabal, J. (Jesús); Rubio, B. (Belén); Feltes-Ochoa, R. (Rosa); Puertolas, T. (Teresa); Drozdowskyj, A. (Ana); Rodrigo, A. (Alberto); Rodríguez-Jiménez, P. (Pedro); Provencio, M. (Mariano); Martínez-Vila, C. (Clara); Berrocal, A. (Alfonso); Crespo, G. (Guillermo); Rodríguez-Moreno, J.F. (Juan Francisco); Mujica, K. (Karmele); Ayala-De-Miguel, P. (Pablo)
    Background The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ( GRAVID ).Methods The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pandemic, as well as to explore the effect of melanoma treatment and tumor stage on the risk of COVID-19 complications. These are the final data of the register, including cases from February 2020 to September 2021.Results One hundred-fifty cases were registered. Median age was 68 years (range 6-95), 61 (40%) patients were females, and 63 (42%) patients had stage IV. Thirty-nine (26%) were on treatment with immunotherapy, and 17 (11%) with BRAF-MEK inhibitors. COVID-19 was resolved in 119 cases, including 85 (57%) patients cured, 15 (10%) that died due to melanoma, and 20 (13%) that died due to COVID-19. Only age over 60 years, cardiovascular disorders, and diabetes mellitus increased the risk of death due to COVID-19, but not advanced melanoma stage nor melanoma systemic therapies. Three waves have been covered by the register: February-May 2020, August-November 2020, and December 2020-April 2021. The first wave had the highest number of registered cases and COVID-19 mortality.Conclusion Tumor stage or melanoma treatments are non-significant prognostic factors for COVID-19 mortality. During the pandemic in Spain there was a downward trend in the number of patients registered across the waves, as well as in the severity of the infection.